Despite the rapid emergence of glucagonlike peptide-1 agonists for treating obesity, bariatric surgery may still be a better choice for some individuals, two experts say.
A rise in total knee arthroplasty doesn’t appear to be due to operations on healthier patients, according to a meta-analysis. Questions remain about the best time for patients to undergo the procedure.
Liraglutide combined with endoscopic bariatric therapy can provide weight loss on par with bariatric surgery alone, raising the question of whether the GLP-1 RAs might one day replace surgery.
The weight loss drug showed a consistent reduction in major cardiovascular events over a 3-year follow up in patients with a history of heart disease who were overweight or obese.